⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001826818

Dolan Daniel

Reports to the SEC for 2 companies · WALTHAM, MA

Transactions

8

Companies

2

Filings

4

CIK

0001826818

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-08-11	Nabriva Therapeutics plcShare OptionsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−83.2K sh	—	—	0
2022-08-11	Nabriva Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−41.6K sh	—	—	0
2022-08-11	Nabriva Therapeutics plcStock Appreciation RightM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+83.2K sh	—	—	83,200
2022-08-11	Nabriva Therapeutics plcPhantom SharesM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+41.6K sh	—	—	41,600
2022-01-28	Nabriva Therapeutics plcShare OptionsA Award	Chief Financial Officer	AAward	+83.2K sh	—	—	83,200
2022-01-28	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Chief Financial Officer	AAward	+41.6K sh	—	—	41,600
2021-03-31	Nabriva Therapeutics plcStock OptionA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2020-11-09	Radius Health, Inc.Stock Option (Right to Buy)A Award	VP of Finance	AAward	+12K sh	—	—	12,000

Recent filings

4

Accepted (ET)
Aug 154
Dolan Daniel0001104659-22-091490
SEC(opens sec.gov)
Feb 14
Dolan Daniel0001104659-22-010489
SEC(opens sec.gov)
Apr 24
Dolan Daniel0001104659-21-046191
SEC(opens sec.gov)
Nov 104
Dolan Dan0001209191-20-057756
SEC(opens sec.gov)

Companies

2

Address

C/O RADIUS HEALTH, INC. 950 WINTER STREET

WALTHAM, MA, 02451